Kathryn Rae Wagner


1989 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kathryn Rae Wagner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Duchenne Muscular Dystrophy Medicine & Life Sciences
Facioscapulohumeral Muscular Dystrophy Medicine & Life Sciences
Muscles Medicine & Life Sciences
Myostatin Medicine & Life Sciences
Muscular Dystrophies Medicine & Life Sciences
Skeletal Muscle Medicine & Life Sciences
Dystrophin Medicine & Life Sciences
Regeneration Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2020

  • 83 Article
  • 2 Review article
  • 1 Chapter
  • 1 Conference contribution

Stem cell-based therapies for Duchenne muscular dystrophy

Sun, C., Serra, C., Lee, G. & Wagner, K. R., Jan 2020, In : Experimental Neurology. 323, 113086.

Research output: Contribution to journalReview article

Pluripotent Stem Cells
Duchenne Muscular Dystrophy
Cell- and Tissue-Based Therapy
Stem Cells
Stem Cell Research

AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice

Nance, M. E., Shi, R., Hakim, C. H., Wasala, N. B., Yue, Y., Pan, X., Zhang, T., Robinson, C. A., Duan, S. X., Yao, G., Yang, N. N., Chen, S. J., Wagner, K. R., Gersbach, C. A. & Duan, D., Jan 1 2019, In : Molecular Therapy.

Research output: Contribution to journalArticle

Muscle Cells
Stem Cells
Clustered Regularly Interspaced Short Palindromic Repeats

Benign tumors in myotonic dystrophy type I target disease-related cancer sites

Alsaggaf, R., St. George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., Liu, Z., Koshiol, J., Bauer, A. J., Wagner, K. R., Greene, M. H., Amr, S. & Gadalla, S. M., Jan 1 2019, In : Annals of Clinical and Translational Neurology. 6, 8, p. 1510-1518 9 p.

Research output: Contribution to journalArticle

Open Access
Myotonic Dystrophy
Confidence Intervals
Brain Neoplasms

Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): Protocol of a large, international, multi-center prospective study

Lorusso, S., Johnson, N. E., McDermott, M. P., Eichinger, K., Butterfield, R. J., Carraro, E., Higgs, K., Lewis, L., Mul, K., Sacconi, S., Sansone, V. A., Shieh, P., Van Engelen, B., Wagner, K., Wang, L., Statland, J. M., Tawil, R., Dimachkie, M., Pasnoor, M., Roath, K. & 32 others, McCalley, A., Currence, M., Herbelin, L., Hamel, J., Arnold, W. D., Alexander, T., Yankie, M., Kelly, K., Holmberg, B., Diaz, L., Jones, A., Butler, A., Moldt, S., Wilson, A., McIntyre, M., Leung, D., Bibat, G., Yep, M., Stinson, N., Jaworek, A., Sissons-Ross, L., Johnstone, L., Skura, C., Deguzman, D., Cornelissen, Y., Villa, L., Puma, A., Gambella, M., Shi, Y., Garcia, J., Beshiri, F. & Mauro, L., Sep 10 2019, In : BMC neurology. 19, 1, 224.

Research output: Contribution to journalArticle

Open Access
Facioscapulohumeral Muscular Dystrophy
Clinical Trials
Prospective Studies
Pharmaceutical Preparations
Outcome Assessment (Health Care)

Engineering 3D skeletal muscle primed for neuromuscular regeneration following volumetric muscle loss

Gilbert-Honick, J., Wagner, K. R., Mao, H. Q. & Grayson, W. L., Jan 1 2019, Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Society for Biomaterials, 1 p. (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium; vol. 40).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Skeletal Muscle
Cholinergic Receptors